Letybo 50 Units Botulinum Toxin Type A | Elite Direct Pharma

Letybo 50 Units Botulinum Toxin Type A

Please log in to view pricing


This product is a fridge-line, it must be refrigerated. Orders placed on Friday will not be dispatched until the following working day which will be Monday (excluding bank holidays)

This is for the use of healthcare professionals and practitioners only and are not available to the general public

This product may differ from the image on the website

This product is currently out of stock and unavailable.


Letybo is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows in adults <75 years old seen at maximum frown (glabellar lines), when the severity of the facial lines has an important psychological impact.

One vial contains 50 units botulinum toxin type A produced by Clostridium botulinum.

After reconstitution each 0.1 mL of the solution contains 4 units.

Letybo should only be administered by physicians with appropriate qualifications and expertise in this treatment and use of the required equipment.

The recommended dose is a total of 20 units divided into five injections of 4 units (0.1 mL) each: 2 injections in each corrugator supercilii muscle and 1 injection in the procerus muscle.

Botulinum toxin units are not interchangeable from one product to another.

Doses recommended are different from other botulinum toxin preparations.

Treatment interval should not be more frequent than every three months.

In the absence of any undesirable effects secondary to the previous treatment session, initiation of a further treatment session with at least a three-month interval between the treatment sessions is possible.

In case of treatment failure one month after a previous treatment session, i.e. in the absence of significant improvement from baseline, the following approaches may be considered:

• Analysis of the causes of failure, e.g. incorrect muscles injected, injection technique, formation of toxin neutralising antibodies, insufficient dose.

• Re-evaluation of the relevance of treatment with botulinum toxin type A.

The efficacy and safety of repeat injections of Letybo beyond 12 months has not been evaluated.

FOR MORE INFORMATION, PLEASE VISIT https://www.medicines.org.uk/emc/product/13707/smpc#gref


Please be aware – This is a prescription only medicine (POM) and will not be processed without receiving a copy of a valid private prescription from a registered UK prescriber 

Additional information


Prescription item zero VAT (£80.00)


There are no reviews yet.

Be the first to review “Letybo 50 Units Botulinum Toxin Type A”

Your email address will not be published. Required fields are marked *